Emily S. Weg

412 total citations
23 papers, 266 citations indexed

About

Emily S. Weg is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, Emily S. Weg has authored 23 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 6 papers in Radiation. Recurrent topics in Emily S. Weg's work include Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Emily S. Weg is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Emily S. Weg collaborates with scholars based in United States, Australia and Canada. Emily S. Weg's co-authors include Subhiksha Nandakumar, Bastien Nguyen, Konrad H. Stopsack, Wassim Abida, Philip W. Kantoff, Nikolaus Schultz, Howard I. Scher, Michael J. Morris, David B. Solit and Melanie Hullings and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Emily S. Weg

20 papers receiving 265 citations

Peers

Countries citing papers authored by Emily S. Weg

Since Specialization

Citations

This map shows the geographic impact of Emily S. Weg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily S. Weg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily S. Weg more than expected).

Fields of papers citing papers by Emily S. Weg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily S. Weg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily S. Weg. The network helps show where Emily S. Weg may publish in the future.

Co-authorship network of co-authors of Emily S. Weg

This figure shows the co-authorship network connecting the top 25 collaborators of Emily S. Weg. A scholar is included among the top collaborators of Emily S. Weg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily S. Weg. Emily S. Weg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	American Brachytherapy Society (ABS) rectoprostatic gel spacer consensus statement 2025 ·Brachytherapy ·Aurélie Garant, Craig E. Grossman, Martin T. King, (unknown), Emily S. Weg, Daniel N. Costa, Hong Zhang, Jeffrey Gahan, (unknown), Lara Hathout, Michael R. Folkert	0
2	Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review 2024 ·Future Oncology ·(unknown), (unknown), Evan Hall, Raquibul Hannan, Jay J. Liao, Alexander V. Louie, Ting Martin, Sarah P. Psutka, Ramesh Rengan, Shankar Siva, Anand Swaminath, Lisa Tachiki, Chad Tang, Bin S. Teh, Joseph Tsai, Scott S. Tykodi, Emily S. Weg, Nicholas G. Zaorsky, Simon S. Lo	4
3	The expanding role of radiation oncology across the prostate cancer continuum 2024 ·Abdominal Radiology ·(unknown), Jay J. Liao, Jonathan Chen, Katherine Kim, Ting Martin, Emily S. Weg	1
4	Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications 2024 ·Abdominal Radiology ·(unknown), Heather H. Cheng, Emily S. Weg, Eric H. Kim, Delphine L. Chen, Amir Iravani, Joseph E. Ippolito	1
5	Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board 2024 ·Prostate Cancer and Prostatic Diseases ·Stacy Loeb, Heather H. Cheng, Channing J. Paller, Emily S. Weg, Jennifer M. Johnson, (unknown), Scott W. Keith, (unknown), (unknown), (unknown), Veda N. Giri	1
6	Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older 2024 ·Frontiers in Oncology ·Fady Ghali, Sarah K. Holt, (unknown), Jonathan J. Chen, Emily S. Weg, Jay J. Liao, Jing Zeng, Petros Grivas, Jessica E. Hawley, Andrew C. Hsieh, Bruce Montgomery, Jonathan L. Wright	0
7	The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma 2023 ·Cancers ·Andrew B. Barbour, Simon Kirste, (unknown), Shankar Siva, Alexander V. Louie, Hiroshi Onishi, Anand Swaminath, Bin S. Teh, Sarah P. Psutka, Emily S. Weg, Jonathan J. Chen, Jing Zeng, John L. Gore, Evan Hall, Jay J. Liao, Rohann Correa, Simon S. Lo	2
8	Framework for Radiation Oncology Department-wide Evaluation and Implementation of Commercial Artificial Intelligence Autocontouring 2023 ·Practical Radiation Oncology ·(unknown), (unknown), Juergen Meyer, John Kang, (unknown), (unknown), D Melançon, Emily S. Weg, Yolanda D. Tseng, (unknown), Stephen R. Bowen	7
9	Proton Radiation Therapy for Stage IIA/IIB Testicular Seminoma 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Jing Zeng, Jiajun Chen, Emily S. Weg, William Ellis, Sarah P. Psutka, Yaw A. Nyame, Todd Yezefski, Daniel Lin, George R. Schade, Jay J. Liao	1
10	Radiomic Analysis to Predict Histopathologically Confirmed Pseudoprogression in Glioblastoma Patients 2022 ·Advances in Radiation Oncology ·Anna Sophia McKenney, Emily S. Weg, Tejus Bale, Aaron T. Wild, Hyemin Um, Michael J. Fox, Andrew Lin, Jonathan T. Yang, (unknown), Maxwell Birger, Florent Tixier, (unknown), Nelson S. Moss, Robert J. Young, Harini Veeraraghavan	14
11	Clinical impact of PSMA PET in patients with biochemically recurrent prostate cancer after locoregional definitive therapy. 2022 ·Journal of Clinical Oncology ·(unknown), (unknown), Atreya Dash, William J. Ellis, (unknown), Jonathan J. Chen, Emily S. Weg, Heather H. Cheng, Petros Grivas, Jessica E. Hawley, John K. Lee, Bruce Montgomery, Peter S. Nelson, Michael T. Schweizer, Todd Yezefski, Evan Y. Yu, Daniel W. Lin, Delphine L. Chen	2
12	Clinical Trial Considerations for Bladder Preservation in Muscle-Invasive Bladder Cancer 2022 ·Benjamin Miron, Jessica E. Hawley, Daniel M. Geynisman, Kent W. Mouw, John P. Sfakianos, Emily S. Weg, Fady Ghali, Jonathan L. Wright, Petros Grivas, Ali Raza Khaki	2
13	A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy 2021 ·Advances in Radiation Oncology ·Matthew D. Greer, Stephanie K. Schaub, Stephen R. Bowen, Jay J. Liao, Kenneth Russell, Jonathan J. Chen, Emily S. Weg, Juergen Meyer, (unknown), George R. Schade, John L. Gore, Sarah P. Psutka, Bruce Montgomery, Michael T. Schweizer, Evan Y. Yu, Petros Grivas, Jonathan L. Wright, Jing Zeng	3
14	Assessing the Risk of Pathologic Lymph Node Involvement in Intermediate Risk Prostate Cancer 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Emily S. Weg, Sarah K. Holt, (unknown), George R. Schade, Jonathan L. Wright, William Ellis, Daniel W. Lin, Lawrence D. True, Jiajun Chen, Jing Zeng, Jay J. Liao, Yaw A. Nyame	1
15	Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer 2020 ·Clinical Cancer Research ·Konrad H. Stopsack, Subhiksha Nandakumar, Andreas G. Wibmer, Samuel Haywood, Emily S. Weg, Ethan Barnett, (unknown), Emily Carbone, (unknown), Bastien Nguyen, Melanie Hullings, Howard I. Scher, Michael J. Morris, David B. Solit, Nikolaus Schultz, Philip W. Kantoff, Wassim Abida	119
16	Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics 2020 ·European Urology ·Bastien Nguyen, José Maurício Mota, Subhiksha Nandakumar, Konrad H. Stopsack, Emily S. Weg, Dana E. Rathkopf, Michael J. Morris, Howard I. Scher, Philip W. Kantoff, Anuradha Gopalan, Dmitriy Zamarin, David B. Solit, Nikolaus Schultz, Wassim Abida	76
17	Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data 2019 ·Advances in Radiation Oncology ·Emily S. Weg, Xin Pei, Marisa Kollmeier, Sean M. McBride, Michael J. Zeléfsky	10
18	Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Emily S. Weg, Marisa Kollmeier, Sean M. McBride, Xin Pei, Michael J. Zeléfsky	0
19	Placement of an Absorbable Rectal Hydrogel Spacer in Patients Undergoing Low-Dose-Rate Brachytherapy with Pd-103 Seeds 2017 ·Brachytherapy ·Amandeep Taggar, (unknown), Emily S. Weg, Marisa Kollmeier, Michael J. Zeléfsky	1
20	Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer 2015 ·Urology ·Zachary A. Kohutek, Emily S. Weg, Xin Pei, Weiji Shi, Zhigang Zhang, Marisa Kollmeier, Michael J. Zeléfsky	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact